(Date:10/10/2008)... (a) levels boost cardiovascular disease risk for... News) -- If you,re worried about reducing your ri...t you should quit smoking, eat a healthful diet, e...ck, and make sure your cholesterol levels aren,t t...in (a) levels are? , Well, if you don,t have a...
(Date:10/10/2008)...ct. 10 /PRNewswire/ -- Do you think that the blind... town? Attend the October,17 open house at the Vir...on Impaired, and see how instructors there empower...e, fulfilling lives through non-visual,techniques ... Azalea Avenue, is holding an open house to,celebr...
(Date:10/10/2008)... Topics range from bullying to incorporating ... (Vocus) October 10, 2008 -- Several pediatric exp...l be presenting at the 2008 American Academy of Pe... runs from October 11 - 14 in Boston. Presenters a...a Best, MD, MPH, will present "Promoting Smok...
(Date:10/10/2008)...ct. 10 /PRNewswire-USNewswire/ -- Public interest,...ing convened to make,decisions on the threats pose...-10 October 2008, the 2nd UNEP(2) Open Ended Worki... that would form part of a global framework,on mer...l (GC) in February,2009, where it will be decided ...
Breaking Medicine News(10 mins):Health News:Little-Known Fat Can Be a Heartbreaker 2Health News:Little-Known Fat Can Be a Heartbreaker 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:Children's National Experts Presenting at American Academy of Pediatrics Conference 2Health News:Elements for a UN Global Framework on Mercury Agreed to 2...ost their lives in Pakistan due to the outbreak of...// Another 40 people are reported to have been inf...having contracted Crimean-Congo hemorrhagic fever ...r, while 40 others are infected and are under obse...
...ase in the HIV/AIDS cases in India’s West Bengal S...age group// of 15 years and 49 years carrying the ...tate AIDS Prevention and Control Society (WBSACS)....ly high. The 2001 census figure put the total popu...
...Left Behind law has focused mainly on providing ch...ment of the child.// A new study now says that pro...also go a long way in improving overall academic p...esearchers by University of Washington's Social De...
...ed that about 6 out of 10 parents of hyperactive c...der (ADHD) are not getting// enough sleep. The mot...he drugs firm Eli Lilly and National Attention Def...upport Service (ADDISS) is to help parents tackle ...
Other Medicine News:Health News:Dengue Fever Claims Five Lives In Pakistan 2Health News:AIDS Cases On The Rise In West Bengal 2Health News:Developing Specific Skills Ensure Better Grades In US Kids 2(Date:10/7/2008)... - Burcon NutraScience,Corporation (TSX-V: BU) ann...) canola protein isolates are GRAS (Generally Reco...y of food and beverage,applications. The products ...t evaluation by a panel of qualified experts in th...ciences, food allergies and pediatric,nutrition. B...
(Date:10/7/2008)...l/ -- CEL-SCI Corporation,(NYSE: CVM ) announced ...,Agreement (MTA) with the National Institutes of H...f Dr. Francesco M. Marincola, M.D., to,investigate...environment,caused by CEL-SCI,s cancer drug Multik...Disease and Immunogentics Section, Department of T...
(Date:10/7/2008)... -- A study published in the,scientific journal Na...eported that InVitria,s ( http://www.InVitria.com ...an effective replacement to bovine serum albumin,i...ound state of embryonic stem cell,self-renewal," d...mbinant,albumin in place of animal-derived serum t...
(Date:10/7/2008)... Taligen Therapeutics Inc.,today announced that in...ndidates were presented at the XXII International ...a highlighted the candidates, efficacy in,several ...These highlighted presentations, as well as severa...veal the deep expertise and expanding,knowledge ba...
Breaking Medicine Technology:Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4Publication Provides a Wake Up Call For Clinicians Treating Narcolepsy 16404 1United Heartland Group Program Earns Record Dividend 16399 1United Heartland Group Program Earns Record Dividend 16399 2AUDIO from Medialink and Nationwide Childrens Hospital 3A Gymnastics a High Injury Risk for Girls 16395 1The story of Max Perutz a pioneering biologist with a remarkable passion for life 2832 1..., June 07, 2007 /PRNewswire-FirstCall/ -,Neurochem...ed,subsidiary of Neurochem Inc. , announces that t...d the results of the "Eprodisate,For AA Amyloidosi...l trial in the search for a treatment of AA amyloi...ial for eprodisate,(KIACTA(TM)) demonstrate that t...
...ting zonisamide SR as a novel component in,EMPATIC...2007 /PRNewswire-FirstCall/ -- Orexigen(TM),Therap... on the,treatment of central nervous system disord...ced results from a Phase I trial evaluating,safety...ustained-release (SR) formulation of zonisamide. I...
Other Medicine Technology:Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 2Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 3Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 4Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 5OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4Kit is supplied with four secondary bars. Secondary bars attach to primary bar. Length 12 (305 mm).
TEW hooked micro-retractor blade set.
Budde retractor blades are designed for the retraction of nerves, vessels, delicate tissue and basal lesions, as well as brain retraction. Equalized brain retraction pressure. Decreased shear injury
...des are designed for the retraction of nerves, ves...ain. Equalizes brain retraction pressure. Decrease...or. Used in conjunction with the Budde Halo Retrac... 2 mm and 4 mm wide. Quick change and release, mal...
Medicine Products: